What is the treatment for Tick-Borne Relapsing Fever (TBRF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Tick-Borne Relapsing Fever (TBRF)

Doxycycline is the definitive treatment of choice for tick-borne relapsing fever and should be initiated immediately upon clinical suspicion without waiting for laboratory confirmation. 1

First-Line Treatment

Adults:

  • Doxycycline 100 mg twice daily (orally or intravenously) 2, 1
  • Duration: 5-7 days minimum and at least 3 days after fever resolution and clinical improvement 1

Children:

  • Doxycycline 2.2 mg/kg body weight twice daily (orally or intravenously) for children weighing <45 kg 2, 1
  • Despite historical concerns, doxycycline is now recommended for children of all ages with TBRF 2
  • Limited courses of doxycycline do not pose substantial risk for tooth staining in children 2

Alternative Treatments

For patients with severe doxycycline allergy:

  • Penicillin V or Penicillin G preparations are effective alternatives 3
  • Erythromycin can be used as an alternative macrolide option 3, 4

For pregnant patients:

  • Tetracyclines are generally contraindicated during pregnancy but may be warranted in life-threatening situations 2
  • Carefully weigh risks and benefits as TBRF during pregnancy can lead to serious complications including spontaneous abortion, preterm delivery, or perinatal mortality 5

Clinical Response Expectations

  • Fever typically subsides within 24-48 hours after initiating appropriate treatment 1
  • If no clinical improvement occurs within 48 hours, consider alternative diagnoses 2, 1

Important Monitoring Considerations

Jarisch-Herxheimer Reaction (JHR)

  • Patients must be closely monitored for Jarisch-Herxheimer reactions after initiating antibiotic therapy 4
  • JHR occurs in approximately 19.3% of TBRF cases 6
  • Characterized by acute worsening of symptoms, fever, hypotension, and tachycardia within hours of first antibiotic dose
  • Supportive care is essential during JHR episodes

Diagnostic Considerations

  • Laboratory confirmation is made by detection of spirochetes in thin or thick blood smears obtained during a febrile episode 4
  • Blood samples should be collected during febrile periods when spirochetemia is highest
  • Microscopy remains the diagnostic gold standard in most clinical settings 6

Prevention Strategies

  • Preventive antibiotic therapy is not recommended for patients with recent tick bites who are not ill 2
  • In endemic regions, avoid rodent and tick-infested areas
  • Use insect repellents and protective clothing to prevent tick bites 4

Treatment Pitfalls to Avoid

  • Do not delay treatment while awaiting laboratory confirmation 1
  • Avoid sulfa-containing antimicrobials, which have been associated with increased severity of tick-borne rickettsial diseases 2
  • Beta-lactams, macrolides, aminoglycosides, and sulfonamides are generally not effective for other tick-borne rickettsial diseases, but penicillins are specifically effective for TBRF 2, 3
  • Do not mistake rash development during treatment as a drug eruption, as it may be a manifestation of the illness itself 2

Early diagnosis and prompt treatment are essential to prevent complications and reduce mortality associated with TBRF.

References

Guideline

Maladies Rickettsiales Transmises par les Tiques

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tick-borne relapsing fever.

American family physician, 2005

Research

Tick-borne relapsing fever during pregnancy: a case report.

The Journal of reproductive medicine, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.